PolyNovo announces change in substantial holding
A substantial holder has changed their holding in the company, as per ASX filing.
See the latest news and media coverage for PolyNovo. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of synthetic skin substitutes
polynovo.comLast updated
In short: PolyNovo achieved record FY26 revenue and commercial sales growth while undergoing significant leadership changes and US clinical progress.
A substantial holder has changed their holding in the company, as per ASX filing.
The company lodged a disclosure with the ASX regarding a change in a substantial holder's interest.
The company announced completion of the clinical study report and provided an update on the PMA submission process.
A substantial holder has ceased to hold a relevant interest in PolyNovo shares.
In a report released today, John Hester from Bell Potter downgraded Polynovo to a Hold, with a price target of A$1.00. Claim 55% Off TipRanks...
PolyNovo posts record group revenue, robust cash flow, and surging commercial sales for FY26, with a positive outlook for ...
Following last week's revelations of corporate governance turmoil, Polynovo chief Swami Raote will depart the company ASX300 entrant Botanix's perspiration in the US is paying...
An announcement from Polynovo ( (AU:PNV) ) is now available.
Track PolyNovo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to PolyNovo and other trending companies.